{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T14:23:36Z","timestamp":1648650216963},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Colombiana de Psiquiatr\u00eda"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.rcp.2015.05.007","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T16:36:21Z","timestamp":1435077381000},"page":"131-136","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluaci\u00f3n y seguimiento hematol\u00f3gico del paciente con diagn\u00f3stico de esquizofrenia"],"prefix":"10.1016","volume":"44","author":[{"given":"Nathalie","family":"Tamayo Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Patricia","family":"Boh\u00f3rquez Pe\u00f1aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Garc\u00eda Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Eduardo","family":"Jaramillo Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio J.","family":"\u00c1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"G\u00f3mez-Restrepo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Arenas Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcp.2015.05.007_bib0145","series-title":"The American Psychiatric Publishing Textbook of Schizophrenia","first-page":"472","author":"Lieberman","year":"2007"},{"issue":"5","key":"10.1016\/j.rcp.2015.05.007_bib0150","first-page":"251","article-title":"Consenso sobre la salud f\u00edsica del paciente con esquizofrenia de las Sociedades Espa\u00f1olas de Psiquiatr\u00eda y de Psiquiatr\u00eda Biol\u00f3gica","volume":"36","author":"S\u00e1iz Ruiz","year":"2008","journal-title":"Actas Esp Psiquiatr."},{"issue":"3","key":"10.1016\/j.rcp.2015.05.007_bib0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.rcp.2015.05.007_bib0160","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.psc.2007.07.006","article-title":"Hematologic problems in psychosomatic medicine","volume":"30","author":"Becker","year":"2007","journal-title":"Psychiatr Clin North Am."},{"issue":"5","key":"10.1016\/j.rcp.2015.05.007_bib0165","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0033-3182(99)71206-5","article-title":"Hematologic side effects of psychotropics","volume":"40","author":"Oyesanmi","year":"1999","journal-title":"Psychosomatics."},{"issue":"6","key":"10.1016\/j.rcp.2015.05.007_bib0170","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.12r08064","article-title":"Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?","volume":"74","author":"Nielsen","year":"2013","journal-title":"J Clin Psychiatry."},{"issue":"8","key":"10.1016\/j.rcp.2015.05.007_bib0175","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.2013.13040447","article-title":"Bipolar disorder, schizophrenia, and metabolic syndrome","volume":"170","author":"Bartoli","year":"2013","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.rcp.2015.05.007_bib0180","doi-asserted-by":"crossref","unstructured":"Mendelson SD. Metabolic Syndrome and Psychiatric Illness: Interactions, Pathophysiology, Assessment and Treatment. Academic Press; 2008. 221.","DOI":"10.1016\/B978-012374240-7.50006-1"},{"issue":"1","key":"10.1016\/j.rcp.2015.05.007_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psym.2012.11.001","article-title":"QTc prolongation, torsades de pointes, and psychotropic medications","volume":"54","author":"Beach","year":"2013","journal-title":"Psychosomatics."},{"issue":"4","key":"10.1016\/j.rcp.2015.05.007_bib0190","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1002\/jhm.691","article-title":"The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?","volume":"5","author":"Meyer-Massetti","year":"2010","journal-title":"J Hosp Med Off Publ Soc Hosp Med."},{"issue":"1","key":"10.1016\/j.rcp.2015.05.007_bib0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr Bull."},{"issue":"4","key":"10.1016\/j.rcp.2015.05.007_bib0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0269881107075509","article-title":"Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia","volume":"21","author":"Barnett","year":"2007","journal-title":"J Psychopharmacol Oxf Engl."},{"issue":"6","key":"10.1016\/j.rcp.2015.05.007_bib0205","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.eurpsy.2009.01.005","article-title":"Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)","volume":"24","author":"De Hert","year":"2009","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr."},{"issue":"2","key":"10.1016\/j.rcp.2015.05.007_bib0210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.bp.110.084665","article-title":"Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation","volume":"199","author":"De Hert","year":"2011","journal-title":"Br J Psychiatry J Ment Sci."},{"issue":"3","key":"10.1016\/j.rcp.2015.05.007_bib0215","first-page":"114","article-title":"Delphi consensus on the physical health of patients with schizophrenia: evaluation of the recommendations of the Spanish Societies of Psychiatry and Biological Psychiatry by a panel of experts","volume":"40","author":"Bobes-Garc\u00eda","year":"2012","journal-title":"Actas Esp Psiquiatr."},{"issue":"5","key":"10.1016\/j.rcp.2015.05.007_bib0220","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/08039488.2010.500397","article-title":"Swedish clinical guidelines--prevention and management of metabolic risk in patients with severe psychiatric disorders","volume":"64","author":"Gothefors","year":"2010","journal-title":"Nord J Psychiatry."},{"key":"10.1016\/j.rcp.2015.05.007_bib0225","year":"2009","journal-title":"Ministry of Health, Malaysia., Management of Schizophrenia in, adults."},{"key":"10.1016\/j.rcp.2015.05.007_bib0230","doi-asserted-by":"crossref","unstructured":"Metabolic and lifestyle issues and severe mental illness - new connections to well-being? J Psychopharmacol (Oxf). 1 de noviembre de 2005; 19(6 suppl):118-22.","DOI":"10.1177\/0269881105058986"},{"key":"10.1016\/j.rcp.2015.05.007_bib0235","unstructured":"Ministerio de la Protecci\u00f3n Social - COLCIENCIAS. Gu\u00eda Metodol\u00f3gica para la elaboraci\u00f3n de Gu\u00edas Atenci\u00f3n Integral en el Sistema General de Seguridad Social en Salud Colombiano [Internet]. Bogot\u00e1. Colombia; 2010. Recuperado a partir de: http:\/\/www.minsalud.gov.co\/salud\/Documents\/Gu%C3%ADa%20Metodol%C3%B3gica%20para%20la%20elaboraci%C3%B3n%20de%20gu%C3%ADas.pdf"},{"key":"10.1016\/j.rcp.2015.05.007_bib0240","unstructured":"Ministerio de Salud y Protecci\u00f3n Social - Colciencias - IETS. Gu\u00eda de pr\u00e1ctica cl\u00ednica para el diagn\u00f3stico, tratamiento e inicio de la rehabilitaci\u00f3n psicosocial de los adultos con esquizofrenia [Internet]. 2014. Recuperado a partir de: http:\/\/gpc.minsalud.gov.co"},{"issue":"1","key":"10.1016\/j.rcp.2015.05.007_bib0245","first-page":"CD000059","article-title":"Clozapine versus typical neuroleptic medication for schizophrenia","author":"Essali","year":"2009","journal-title":"Cochrane Database Syst Rev Online."},{"issue":"11","key":"10.1016\/j.rcp.2015.05.007_bib0250","first-page":"CD006633","article-title":"Clozapine versus other atypical antipsychotics for schizophrenia","author":"Asenjo Lobos","year":"2010","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"10.1016\/j.rcp.2015.05.007_bib0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.rpsm.2011.11.003","article-title":"Clozapine and agranulocitosis in Spain: do we have a safer population?. A 5-year hematologic follow-up","volume":"5","author":"Pons","year":"2012","journal-title":"Rev Psiquiatr Salud Ment."},{"key":"10.1016\/j.rcp.2015.05.007_bib0260","unstructured":"NICE. CG82 Schizophrenia (update): full guideline [Internet]. NICE. [citado 3 de mayo de 2013]. Recuperado a partir de: http:\/\/www.nice.org.uk\/"},{"key":"10.1016\/j.rcp.2015.05.007_bib0265","unstructured":"National Collaborating Centre for Mental Health, commissioned by the National Institute for Health & Clinical Excellence. Schizophrenia. Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care (updated edition). National Clinical Guideline Number 82 [Internet]. Printed in Great Britain. Stanley Hunt.; 2010. Recuperado a partir de: http:\/\/www.nice.org.uk\/"},{"issue":"4","key":"10.1016\/j.rcp.2015.05.007_bib0270","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.169.4.483","article-title":"Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland","volume":"169","author":"Atkin","year":"1996","journal-title":"Br J Psychiatry J Ment Sci."},{"issue":"6","key":"10.1016\/j.rcp.2015.05.007_bib0275","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/hup.779","article-title":"Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?","volume":"21","author":"Kang","year":"2006","journal-title":"Hum Psychopharmacol."},{"issue":"3","key":"10.1016\/j.rcp.2015.05.007_bib0280","first-page":"233","article-title":"Blood dyscrasias in clozapine-treated patients in Italy","volume":"85","author":"Lambertenghi Deliliers","year":"2000","journal-title":"Haematologica."}],"container-title":["Revista Colombiana de Psiquiatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034745015000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034745015000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T16:23:11Z","timestamp":1566922991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034745015000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0034745015000694"],"URL":"https:\/\/doi.org\/10.1016\/j.rcp.2015.05.007","relation":{},"ISSN":["0034-7450"],"issn-type":[{"value":"0034-7450","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluaci\u00f3n y seguimiento hematol\u00f3gico del paciente con diagn\u00f3stico de esquizofrenia","name":"articletitle","label":"Article Title"},{"value":"Revista Colombiana de Psiquiatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcp.2015.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Asociaci\u00f3n Colombiana de Psiquiatr\u00eda. Published by Elsevier Spain S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}